Health care stocks experienced modest edit stock price gains, with Johnson & Johnson adding 1.1% after improved guidance. Analysts note favorable reimbursement changes coming into play. 10 stocks we like better than CRISPR Therapeutics › Given the large stake in the stock by institutions, Editas Medicine's stock price might be vulnerable to their trading decisions The latest edit stock price data for tech giants shows mixed momentum, with Nasdaq composite up 0.8%, driven by semiconductor gains. Analysts forecast short-term volatility as inflation print this week could shift market sentiment. Institutional players are closely watching Fed commentary for cues.